A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
Clinical trial NCT00751166 · TERMINATED
Trial details
- NCT number
- NCT00751166
- Sponsor
- Organon and Co
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2005-05-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.